Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Compass Pathways plc
Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
April 22, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
March 26, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression
March 18, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways to Participate in Stifel Virtual CNS Forum
March 11, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights
February 27, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference
February 25, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025
February 18, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 05, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer
January 21, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways Announces Pricing of Underwritten Offering
January 10, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)
December 18, 2024
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways to Participate in December Investor Conferences
November 25, 2024
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates
October 31, 2024
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024
October 24, 2024
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.